Symbol Lookup
CRYOLIFE, Inc. Add to My Watchlist (NYSE: CRY) 

     CRYOLIFE 5.92 -0.23 (-3.74%) 105,872
Profile for CRY
CRYOLIFE, Inc.
1655 Roberts Boulevard, N.W.
Kennesaw, GA 30144
http://www.cryolife.com

CryoLife develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications. Co.'s biomaterials and implantable devices include BioGlue Surgical Adhesive , porcine heart valves, and vascular grafts of bovine tissue processed using its proprietary SynerGraft technology. As of Dec 31 2006, Co. was authorized to distribute BioGlue throughout the U.S. and in more than 60 other countries for designated applications. In addition, Co. distributes the CryoLife O'Brien aortic heart valve, which is a porcine heart valve, in Europe, the Middle East, and Africa.
Headquarters for CRY
Key Facts
Industry Health
Sector Diagnostic Services
# of Employees 388
Shares Outstanding 28.5M
Market Cap 168.5M
Enterprise Value 108.8M
52-Week High $10.14
52-Week Low $3.93
P/E Ratio 5.75
EPS $1.03/shr
Dividend -
Yield -
Key Executives
Ms. Amy D. Horton Chief Accounting Officer
Mr. Steven G. Anderson Chief Executive Officer; Chairman; President
Mr. David Ashley Lee Chief Financial Officer; Chief Operating Officer; Executive Vice President
Dr. Albert E. Heacox Ph.D. Senior Vice President
Mr. Gerald B. Seery Senior Vice President
Mr. David M. Fronk Vice President
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
E-mail Article to a Friend